Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours.

British journal of clinical pharmacology2023Chen X, Isambert N, López-López R, et al.

Study designOther primary literature

SubjectHuman

Record checks

Study design: Other primary literature
Subject: Human
Publication year: 2023
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Area Under CurveBenzamidesCaffeineCytochrome P-450 CYP1A2Cytochrome P-450 CYP3ACytochrome P-450 Enzyme SystemDrug InteractionsHumansImidazolesMidazolamTriazines

DOI 10.1111/bcp.15544

PMID 36131603

View source →